Literature DB >> 12595267

Improving the thermodynamic stability of the leucine zipper of max increases the stability of its b-HLH-LZ:E-box complex.

Naud Jean-François1, Gagnon Frédéric, Wellinger Raymund, Chabot Benoit, Pierre Lavigne.   

Abstract

Max is a member of the b-HLH-LZ (basic region-helix1-loop-helix2-leucine zipper) family of eukaryotic transcription factors. It is the obligate partner of the related b-HLH-LZ proteins, c-Myc and Mad1, with which it forms heterodimers on target DNA. While c-Myc and Mad1 require Max for DNA-binding, Max itself can form a homodimer that recognizes E-box DNA sequences (CACGTG) in gene promoters that are targeted by c-Myc. Evidence suggests that this mode of binding by Max may repress c-Myc transcriptional activity, and this may have applications in the control of the aberrant activity of c-Myc during certain oncogenic transformations. To enhance this repressive potential of Max, we sought to stabilize Max homodimers. We have designed a double mutant (N78V/H81L) located in the coiled-coil interface of the leucine zipper domain and we demonstrate that these mutations do indeed increase the stability of the protein. The mutations also improve the stability of the complex with cognate DNA. Thermal denaturations monitored by circular dichroism reveal two transitions that are due to intermediate folding states for both the wild-type and mutant proteins; this is supported by detailed thermodynamic analyses. A formalism to characterize the temperature-dependence of the unfolding, including the effect of intermediates, is presented.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12595267     DOI: 10.1016/s0022-2836(03)00029-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  6 in total

1.  Max-E47, a designed minimalist protein that targets the E-box DNA site in vivo and in vitro.

Authors:  Jing Xu; Gang Chen; Antonia T De Jong; S Hesam Shahravan; Jumi A Shin
Journal:  J Am Chem Soc       Date:  2009-06-10       Impact factor: 15.419

2.  Intrinsic cell-penetrating activity propels Omomyc from proof of concept to viable anti-MYC therapy.

Authors:  Marie-Eve Beaulieu; Toni Jauset; Daniel Massó-Vallés; Sandra Martínez-Martín; Peter Rahl; Loïka Maltais; Mariano F Zacarias-Fluck; Sílvia Casacuberta-Serra; Erika Serrano Del Pozo; Christopher Fiore; Laia Foradada; Virginia Castillo Cano; Meritxell Sánchez-Hervás; Matthew Guenther; Eduardo Romero Sanz; Marta Oteo; Cynthia Tremblay; Génesis Martín; Danny Letourneau; Martin Montagne; Miguel Ángel Morcillo Alonso; Jonathan R Whitfield; Pierre Lavigne; Laura Soucek
Journal:  Sci Transl Med       Date:  2019-03-20       Impact factor: 17.956

3.  The Max b-HLH-LZ can transduce into cells and inhibit c-Myc transcriptional activities.

Authors:  Martin Montagne; Nicolas Beaudoin; David Fortin; Christine L Lavoie; Roscoe Klinck; Pierre Lavigne
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

4.  Viral mutations enhance the Max binding properties of the vMyc b-HLH-LZ domain.

Authors:  D H Crouch; F Fisher; S A La Rocca; C R Goding; D A F Gillespie
Journal:  Nucleic Acids Res       Date:  2005-09-15       Impact factor: 16.971

5.  Biophysical characterization of the b-HLH-LZ of ΔMax, an alternatively spliced isoform of Max found in tumor cells: Towards the validation of a tumor suppressor role for the Max homodimers.

Authors:  Loïka Maltais; Martin Montagne; Mikaël Bédard; Cynthia Tremblay; Laura Soucek; Pierre Lavigne
Journal:  PLoS One       Date:  2017-03-28       Impact factor: 3.240

Review 6.  Structural and Biophysical Insights into the Function of the Intrinsically Disordered Myc Oncoprotein.

Authors:  Marie-Eve Beaulieu; Francisco Castillo; Laura Soucek
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.